Hivid and Pain exacerbated - a phase IV clinical study of FDA data

Summary:

Pain exacerbated is reported as a side effect among people who take Hivid (zalcitabine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Epivir, and have Hiv infection.

The phase IV clinical study analyzes which people have Pain exacerbated when taking Hivid. It is created by eHealthMe based on reports of 518 people who have side effects when taking Hivid from the FDA, and is updated regularly.

What is Hivid?

Hivid has active ingredients of zalcitabine. eHealthMe is studying from 518 Hivid users. Check the latest studies of Hivid.

What is Pain exacerbated?

Pain exacerbated is found to be associated with 3,987 drugs and 3,018 conditions by eHealthMe. Check the latest studies of Pain exacerbated.

On Jul, 10, 2026

518 people reported to have side effects when taking Hivid.
Among them, 15 people (2.9%) have Pain exacerbated.

Among these 15 people:

How long have people been on Hivid when they have Pain exacerbated? *

What is the gender of people who have Pain exacerbated when taking Hivid? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Pain exacerbated when taking Hivid? *

What are other drugs people take besides Hivid? *

What are other side effects people have besides Pain exacerbated? *

Chills (felling of cold): 4 people, 26.67%
Fever: 3 people, 20.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 13.33%
Bone Pain: 2 people, 13.33%
Influenza Like Illness: 2 people, 13.33%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 13.33%
Joint Stiffness: 2 people, 13.33%
Fall: 2 people, 13.33%
Mouth Ulcers: 2 people, 13.33%
Movement - Uncoordinated: 2 people, 13.33%

What are the existing conditions these people have? *

Hiv Infection: 2 people, 13.33%
High Blood Pressure: 1 person, 6.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 6.67%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.67%
Bacterial Infection: 1 person, 6.67%
Diarrhea: 1 person, 6.67%
Dry Skin: 1 person, 6.67%
Erection Problems: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Stress And Anxiety: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Hivid and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hivid:

Hivid (518 reports)

Browse all side effects of Hivid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain exacerbated:

Pain exacerbated (3,987 drugs)

Browse all the conditions that are associated with Pain exacerbated:

Pain exacerbated (3,018 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zalcitabine (the active ingredients of Hivid) and Hivid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.